Dexamethasone Sodium Phosphate Injection shortage
Dexamethasone Sodium Phosphate Injection is currently listed in shortage by the FDA. The FDA lists 19 affected products. The reported reason: Demand increase for the drug. This page was last refreshed from FDA data on Sep 22, 2026.
Dexamethasone sodium phosphate injection has been on the FDA shortage list for over a year due to high demand. Both available strengths (4 mg/mL and 10 mg/mL) still have listed supply from multiple manufacturers, including Sagent Pharmaceuticals, Eugia, and others not reporting a shortage.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Dexamethasone Sodium Phosphate Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 17, 2026Currently in shortage19 of 19 products affected.
-
Sep 15, 2026FDA refreshed this shortage record9 products updated.
-
Sep 11, 2026FDA refreshed this shortage record2 products updated.
-
Sep 3, 2026FDA refreshed this shortage record3 products updated.
-
Feb 8, 2019First reported to the FDA19 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Eugia US LLC 📞 888-238-7880 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 9 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | — | Limited Availability | 3 month expiry available on request. Next release not available at this time. | Demand increase for the drug |
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | — | Limited Availability | 3 month expiry available on request. Next release not available at this time. | Demand increase for the drug |
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | — | Available | Check wholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | — | Available | Check wholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | — | Available | Check wholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | — | Available | Check wholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | — | Available | Checkwholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | — | Available | Check wholesalers for inventory | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | — | Available | Additional product will be made available as it is released. | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | — | Available | Product will be made available as it is released. | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | — | Available | Additional product will be made available as it is released. | — |
Manufacturer: Mylan Institutional, a Viatris Company 📞 800-796-9526 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | — | Available | — | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | — | Available | — | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | — | Available | — | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | — | Available | — | — |
Manufacturer: Somerset Therapeutics, LLC 📞 732-554-1019 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | — | Available | — | — |
| Current | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Dexamethasone Sodium Phosphate Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Dexamethasone Sodium Phosphate Injection? options further down this page.
Why is Dexamethasone Sodium Phosphate Injection in shortage?
The main reason Dexamethasone Sodium Phosphate Injection is on the FDA shortage list is that more people need it right now than usual — demand has gone up. Most strengths and package sizes from the manufacturers listed in this report are currently showing as "available," but there is one specific product feeling the pinch: Fresenius Kabi's 10 mg/1 mL vial (NDC 76045-0212-10) is listed as having limited availability due to that higher demand. For that particular product, Fresenius Kabi notes that some stock with a 3-month expiration date is available on request, but they are not yet able to say when the next regular release will happen.
For Hikma's products, the company has noted that additional supply will be made available as batches are released from their manufacturing process. Fresenius Kabi also suggests checking with drug wholesalers to locate inventory of their other dexamethasone products. Again, this report covers only the specific manufacturers and products listed here, so availability can vary depending on the source.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Dexamethasone Sodium Phosphate Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Dexamethasone Sodium Phosphate Injection?
Dexamethasone Sodium Phosphate Injection is currently on the FDA drug-shortage list. If you or someone you care for uses this medicine, this is a manageable situation, and I'll explain where supply stands.
Both strengths on this record — the 4 mg/1 mL and the 10 mg/1 mL — still have an available source. Right now, no strength is listed as having zero supply. In fact, all five manufacturers on this record report their products as available, so the shortage does not mean the medicine is gone.
The FDA lists the reason as an increase in demand, and this listing has lasted more than a year. Manufacturers note that more product will be released over time and that pharmacies should check wholesalers for current inventory. Because this medicine is given as an injection, it is almost always handled in a clinical or pharmacy setting rather than by you at home.
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy or clinic to order your strength — they can check wholesalers and multiple manufacturers.
- The same medicine is made by several companies, so your pharmacy may be able to source it from another maker, though it may not be in local stock.
- If your exact product cannot be found, ask your prescriber or pharmacist about clinician-chosen options.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls. This is general, national information and may not match local stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Dexamethasone Sodium Phosphate Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Dexamethasone Sodium Phosphate Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection · Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Hikma Pharmaceuticals USA Inc. | 00641-6146-10 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Sagent Pharmaceuticals | 25021-0052-01 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mL | Injection, Solution · Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Sagent Pharmaceuticals | 25021-0053-01 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intramuscular, Intravenous | A-S Medication Solutions | 50090-0414-00 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mL | Injection · Intramuscular, Intravenous | A-S Medication Solutions | 50090-3541-00 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Eugia US LLC | 55150-0237-01 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 100 mg/10mL | Injection · Intramuscular, Intravenous | Eugia US LLC | 55150-0305-10 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intramuscular, Intravenous | Cardinal Health 107, LLC | 55154-9364-05 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intramuscular, Intravenous | Fresenius Kabi USA, LLC | 63323-0165-16 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mL | Injection, Solution · Intramuscular, Intravenous | Fresenius Kabi USA, LLC | 63323-0506-13 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL | Injection, Solution · Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Mylan Institutional LLC | 67457-0418-05 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mL | Injection, Solution · Intramuscular, Intravenous | Mylan Institutional LLC | 67457-0483-10 |
Alternative dosage forms of Dexamethasone Sodium Phosphate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate 10 mg/mL | Somerset | 10 vials | $0.504 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Fresenius | 10 vials | $0.504 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Mylan | 10 vials | $0.504 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Mylan | 10 vials | $0.504 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Hikma | 25 vials | $1.236 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Civica, | 25 vials | $1.236 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Sagent | 25 vials | $1.293 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Eugia | 25 vials | $1.293 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Fresenius | 25 vials | $1.293 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Somerset | 25 vials | $1.293 | AP | Availability likely |
| Dexamethasone Sodium Phosphate 10 mg/mL | Armas | 25 vials | $1.293 | AP | Availability likely |
| Dexamethasone sodium phosphate 10 mg/mL | Micro | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | A-S | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Gland | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Amneal | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Advanced | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Sportpharm | 1 ml | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Sportpharm | 25 vials | — | AP | FDA listed |
| Dmt Suik 10 mg/mL | Asclemed | 1 vial | — | — | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | HF | 1 ml | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Fresenius | 1 syringe | — | AP | FDA listed |
| Dmt Suik 10 mg/mL | Advanced | 1 vial | — | — | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | HF | 10 ml | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Cardinal | 5 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | REMEDYREPACK | 25 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Asclemed | 10 vials | — | AP | FDA listed |
| Dexamethasone Sodium Phosphate 10 mg/mL | Henry | 1 vial | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Dexamethasone Sodium Phosphate Injection — that fall in the same broad treatment class (glucocorticoids) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Dexamethasone Sodium Phosphate Injection shortage FAQs
Is Dexamethasone Sodium Phosphate Injection in shortage?
Why is Dexamethasone Sodium Phosphate Injection in shortage?
Which products are affected?
When will Dexamethasone Sodium Phosphate Injection be available again?
Can I still get Dexamethasone Sodium Phosphate somewhere?
What should I do if I take Dexamethasone Sodium Phosphate Injection?
Still have a question about the Dexamethasone Sodium Phosphate Injection shortage?
Ask a pharmacist about this shortage →View Dexamethasone Sodium Phosphate Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.